microRNAs: Novel Markers in Diagnostics and Therapeutics of Celiac Disease.


Journal

DNA and cell biology
ISSN: 1557-7430
Titre abrégé: DNA Cell Biol
Pays: United States
ID NLM: 9004522

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 14 5 2019
medline: 20 7 2019
entrez: 14 5 2019
Statut: ppublish

Résumé

microRNAs (miRNAs) are a novel class of single-stranded RNAs with a key role in the regulation of gene expression. miRNA main mechanism of action involves interaction with the mRNA transcribed from the genes, leading to the target mRNA silencing and degradation. Indeed, it is easy to conceive that a defective miRNA-based mRNA regulation may compromise normal cell function and cause genetic diseases. A wide spectrum of studies has focused on the identification and introduction of regulatory diseases-specific miRNAs for the past decade. Overexpression or downregulation of several miRNAs can potentially stimulate or inhibit pathways related to the pathogenesis of celiac disease (CD). CD is a chronic inflammatory disease characterized by small intestinal mucosal injury and nutrient malabsorption in genetically susceptible individuals after the dietary ingestion of gluten. The disease is characterized by villous atrophy, intraepithelial lymphocyte infiltration, and chronic inflammation and activation of lamina propria T cells. The common genetic background in CD is the presence of heterodimeric human leukocyte antigen class II molecules

Identifiants

pubmed: 31081687
doi: 10.1089/dna.2018.4561
doi:

Substances chimiques

Biomarkers 0
HLA-DQ Antigens 0
HLA-DQ2 antigen 0
MicroRNAs 0
Glutens 8002-80-0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

708-717

Auteurs

Elham Chamani (E)

1 Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
2 Department of Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.

Javad Sargolzaei (J)

3 Department of Biology, Faculty of Sciences, Arak University, Arak, Iran.

Tahmineh Tavakoli (T)

1 Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
4 Gastroenterology Section, Department of Internal Medicine, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.

Zohreh Rezaei (Z)

5 Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH